Directori de persones
Luis Brieva Ruiz

Luis Brieva Ruiz

Grau: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/E-8505-2019

Grups

Publicacions

  • Leavitt, VM; Fox, R; Mostert, J; D'Haeseleer, M; Moral, E; Brieva-Ruiz, L; Repovic, P; Bowen, JD; Comtois, J; Uitdehaag, B; Strijbis, E; Cutter, G; Koch, MW

    Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study

    MULTIPLE SCLEROSIS JOURNAL -. .

    [doi:10.1177/13524585251335213]

  • Leavitt, V; Mostert, J; Comtois, J; Moral, E; Brieva, L; Repovic, P; Bowen, JD; Uitdehaag, B; Strijbis, E; Cutter, G; Koch, MW

    Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy

    JOURNAL OF NEUROLOGY 272 338-338. .

    [doi:10.1007/s00415-025-13066-4]

  • Robles-Sánchez, MA; Amil-Bujan, P; Bosch-Farré, C; Coll-Martínez, C; Arévalo, MJ; Anglada-Clofent, E; Menéndez-Díaz, R; Aroca-Alsina, M; Merchan-Ruiz, M; Pérez-Hoyos, S; Arévalo-Bernabé, AG; Montalban, X; Hernando, A; Llufriú, S; Peralta-Moncusi, S; Brieva, L; Ramo-Tello, C; Carabi, M; Solà-Valls, N; Zabay, MC; Mañé-Martínez, MA; Sastre-Garriga, J; Ramió-Torrentà, L; Bertran-Noguer, C

    An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

    Frontiers in Neurology 16 1581038-1581038. .

    [doi:10.3389/fneur.2025.1581038]

  • Brieva L; Calles C; Landete L; Oreja-Guevara C

    Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment.

    Frontiers in Immunology 16 1543649-1543649. .

    [doi:10.3389/fimmu.2025.1543649]

  • Santacreu-Vilaseca, M; Moreno-Magallon, J; Juanes-Casado, A; Gil-Sánchez, A; González-Mingot, C; Torres, P; Brieva, L

    Novel Cell Models to Study Myelin and Microglia Interactions

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 26 -. .

    [doi:10.3390/ijms26052179]

  • Oreja-Guevara, C; Martinez-Yélamos, S; Eichau, S; Llaneza, MA; Martín-Martínez, J; Peña-Martínez, J; Meca-Lallana, V; Alonso-Torres, AM; Moral-Torres, E; Río, J; Calles, C; Ares-Luque, A; Ramió-Torrentà, L; Marzo-Sola, ME; Prieto, JM; Martínez-Ginés, ML; Arroyo, R; Otano-Martínez, MA; Brieva-Ruiz, L; Gómez-Gutiérrez, M; Rodríguez-Antigüedad, A; Sánchez-Seco, V; Costa-Frossard, L; Hernández-Pérez, MA; Landete-Pascual, L; González-Platas, M; Meca-Lallana, JE

    Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

    Therapeutic Advances in Neurological Disorders 17 -. .

    [doi:10.1177/17562864241284372]

  • Monreal, E; Fernández-Velasco, JI; Alvarez-Lafuente, R; de la Maza, SS; García-Sánchez, MI; Llufriu, S; Casanova, B; Comabella, M; Martínez-Yélamos, S; Galimberti, D; Ramió-Torrentà, L; Martínez-Ginés, ML; Aladro, Y; Ayuso, L; Martínez-Rodríguez, JE; Brieva, L; Villarrubia, N; Eichau, S; Zamora, J; Rodero-Romero, A; Espiño, M; Blanco, Y; Saiz, A; Montalbán, X; Tintoré, M; Domínguez-Mozo, MI; Cuello, JP; Romero-Pinel, L; Ghezzi, L; de la Fuente, BP; Pérez-Miralles, F; Quiroga-Varela, A; Rubio, L; Rodríguez-Jorge, F; Chico-García, JL; Sainz-Amo, R; Masjuan, J; Costa-Frossard, L; Villar, LM

    Serum biomarkers at disease onset for personalized therapy in multiple sclerosis

    BRAIN 147 4084-4093. .

    [doi:10.1093/brain/awae260]

  • González-Mingot C.; Gil-Sánchez A.; Begué-Gómez R.; López-Ortega R.; Luis B.R.

    Ischemic encephalopathic debut of CADASIL, a case report: It is better to be safe than sorry

    NEUROLOGIA 39 712-715. .

    [doi:10.1016/j.nrl.2023.02.002]

  • Fernández O; Montalbán X; Agüera E; Aladro Y; Alonso A; Arroyo R; Brieva L; Calles C; Costa-Frossard L; Eichau S; García-Domínguez JM; Hernández MA; Landete L; Llaneza M; Llufriu S; Meca-Lallana JE; Meca-Lallana V; Moral E; Prieto JM; Ramió-Torrentà L; Téllez N; Romero-Pinel L; Vilaseca A; Rodríguez-Antigüedad A

    XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II).

    REVISTA DE NEUROLOGIA 79 51-66. .

    [doi:10.33588/rn.7902.2024174]

  • Fernández, O; Montalbán, X; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Costa-Frossard, L; Eichau, S; García-Domínguez, JM; Hernández, MA; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Moral, E; Prieto, JM; Ramió-Torrentà, L; Téllez, N; Romero-Pinel, L; Vilaseca, A; Rodríguez-Antigüedad, A

    XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)

    REVISTA DE NEUROLOGIA 79 21-29. .

    [doi:10.33588/rn.7901.2024170]

  • Gil-Sánchez A.; Gonzalo H.; Canudes M.; Nogueras L.; González-Mingot C.; Valcheva P.; Torres P.; Serrano J.C.; Peralta S.; Solana M.J.; Brieva L.

    Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

    PHARMACEUTICALS 17 -. .

    [doi:10.3390/ph17040459]

  • Meca-Lallana JE; Martínez Yélamos S; Eichau S; Llaneza MÁ; Martín Martínez J; Peña Martínez J; Meca Lallana V; Alonso Torres AM; Moral Torres E; Río J; Calles C; Ares Luque A; Ramió-Torrentà L; Marzo Sola ME; Prieto JM; Martínez Ginés ML; Arroyo R; Otano Martínez MÁ; Brieva Ruiz L; Gómez Gutiérrez M; Rodríguez-Antigüedad Zarranz A; Sánchez-Seco VG; Costa-Frossard L; Hernández Pérez MÁ; Landete Pascual L; González Platas M; Oreja-Guevara C

    Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.

    NEUROLOGIA 39 196-208. .

    [doi:10.1016/j.nrleng.2024.01.003]

Projectes

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO